Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.
Johnson N, Li YC, Walton ZE, Cheng KA, Li D, Rodig SJ, Moreau LA, Unitt C, Bronson RT, Thomas HD, Newell DR, D'Andrea AD, Curtin NJ, Wong KK, Shapiro GI.
Johnson N, et al. Among authors: bronson rt.
Nat Med. 2011 Jun 26;17(7):875-82. doi: 10.1038/nm.2377.
Nat Med. 2011.
PMID: 21706030
Free PMC article.